Shannon Campbell - 26 May 2026 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Reporting relationship: Director
Issuer ticker: ZNTL
Reported as of: 26 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 May 2026, 16:11:29 UTC
Prior SEC filing: 27 May 2026
Next SEC filing: 29 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ James B. Bucher, attorney-in-fact for Shannon Campbell

Key filing fact

Shannon Campbell filed Form 4 for Zentalis Pharmaceuticals, Inc. (ZNTL) on 27 May 2026.

Key facts

This page summarizes Shannon Campbell's Form 4 filing for Zentalis Pharmaceuticals, Inc. (ZNTL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 May 2026, 16:11.

Change

Previous filing in this sequence was filed on 27 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002018966 Primary reporting owner

Campbell Shannon

Relationship: Director
Address: C/O ZENTALIS PHARMACEUTICALS, INC., 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO
Signature: /s/ James B. Bucher, attorney-in-fact for Shannon Campbell
Signature date: 27 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZNTL transaction

Common Stock

Award

Transaction value
Shares: +114,200
Change %
Price: $0.000000^*
Shares after: 114,200
Date: 26 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The restricted stock units ("RSUs") were granted by the Issuer pursuant to the Issuer's Non-Employee Director Compensation Program. One third of the RSUs will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.